[Image: see text]
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8639564 | PMC |
| http://dx.doi.org/10.1007/s00392-021-01842-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Valve-in-Valve-in-Valve.
BMJ Case Rep
July 2024
Cardiology, University of Fribourg, Fribourg, Switzerland
In the case of the degeneration of surgical aortic valve replacement (SAVR), the transcatheter aortic valve implantation (TAVI) has become the standard. However, these valves are also susceptible to deterioration. In such instances, a new TAVI implantation may be considered.
View Article and Find Full Text PDFRole of imaging in third aortic valve implantation: TAV-in-TAV-in-SAV.
Int J Cardiovasc Imaging
July 2024
Department of Cardiology, University Hospital Zurich, Zurich, 8091, Switzerland.
Coronary obstruction remains a primary concern for redo transcatheter aortic valve implantation (TAVI) due to supra-annular leaflets. Hereby, we present two valve-in-valve-in-valve cases, initially incorporating a surgical valve implanted to clarify our concept that the surgical valve serves to safeguard against the coronary ostium obstruction.
View Article and Find Full Text PDFTransseptal Mitral Valve-in-Valve-in-Valve.
CASE (Phila)
March 2024
The Prince Charles Hospital, Metro North Health, Brisbane, Australia.
• Transseptal MV implantation is performed for many indications. • Previous ViV procedures do not preclude further ViV insertion. • Appropriate sizing of transseptal MVs is essential to reduce complications.
View Article and Find Full Text PDFSuccessful Rescue Transaortic Valve Replacement Using Edwards Sapien 3 Following Failed Evolut R Implantation in a Degenerated Surgical Bioprosthesis: A Case Report.
Cureus
February 2024
Cardiology, VA Caribbean Healthcare System, San Juan, PRI.
This study examines a complex scenario of structural valve degeneration (SVD) in a high surgical-risk patient with a previously implanted 25 mm Carpentier-Edwards (CE) Perimount Magna Ease 3300 (Irvine, CA: Edwards Lifesciences) surgical bioprosthetic valve (SAV), the patient presented with both paravalvular leak (PVL) and central prosthetic valve insufficiency (PVI). The patient was considered for a transaortic valve-in-valve (ViV) intervention with a self-expanding 29 mm Evolut R valve (Minneapolis, MN: Medtronic). The case describes a ViV intervention complicated by the malpositioning of the Evolut R valve secondary to micro-dislodgement into the left ventricular outflow tract (LVOT) after deployment and subsequent migration into the LVOT during an attempted bioprosthetic valve fracture (BVF) of the SAV that aimed to decrease transvalvular gradients.
View Article and Find Full Text PDFTranscatheter mitral valve implantation: Implications of interventional technique and 3D echocardiography for complex valve-in-valve paravalvular leak.
Ann Card Anaesth
November 2023
Weill Cornell Medical College, New York Presbyterian Hospital, Division of Cardiology, 525 E. 68th Street, New York, NY, USA.
Transcatheter mitral valve replacement (TMVR) has emerged as a feasible alternative to surgical reoperation in failed bioprostheses and rings. Residual mitral regurgitation following TMVR can present as a valve-in-valve paravalvular leak (PVL) and is associated with increased morbidity and mortality. Current therapies for valve-in-valve PVL are limited.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!